Journal profile · Dermatology
Skin Pharmacology and Physiology
ISSN 1660-5527 · eISSN 1660-5535 · S. Karger AG · UNITED STATES · Bimonthly · Founded 2004
Skin Pharmacology and Physiology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 4.05; hybrid open access; median 128 days to acceptance (58 articles, last 24 months); community-reported acceptance: fairly easy; 30 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Skin Pharmacology and Physiology is published by S. Karger AG and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Advancements in Transdermal Drug Delivery, Dermatology and Skin Diseases and Skin Protection and Aging, together about 43.7% of its articles. Its main subfields are Dermatology. (generated from OpenAlex topic counts and CAS ranking data)
Topical therapies are the main interest of this journal that seeks submissions of original papers and systematic reviews in pharmacological aspects of the skin and skin physiology. Modulation of the epidermis (e.g. epidermal barrier function), exogenous influences on skin functions, studies of skin physiology (if performed with non-invasive instruments), and the study of the regulatory pathways involved in skin penetration of topical formulations through in vivo and in vitro models are invited. Studies with well-characterized active ingredients performed on animals will not be accepted but may be eligible if specific pathways or modes of action with little or no published data are studied. Systemic treatment studies on epidermal functions and innovative approaches to methodology, skin pharmacology or clinically relevant problems and cosmetic studies with relevant effects on skin physiology and an appropriate control (i.e. placebo, not comparison to baseline) may be submitted.
From the journal's Aims & Scope
Research area (LetPub): Dermatology
Editor-in-chief Jürgen LademannPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics18.2%
- Dermatology and Skin DiseasesMedicine13.3%
- Skin Protection and AgingMedicine12.2%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance6.5%
- Human auditory perception and evaluationEngineering6.2%
- Contact Dermatitis and AllergiesMedicine6%
- Wound Healing and TreatmentsMedicine3.7%
- Acne and Rosacea Treatments and EffectsMedicine2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Dermatology | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.05LetPub ·
- Impact factor (publisher)
- 4.1Publisher website ·
- CiteScore 2026-06
- 7LetPub ·
- CiteScore (publisher)
- 7Publisher website ·
- SJR 2026-06
- 0.98LetPub ·
- SNIP 2026-06
- 1.07LetPub ·
- h-index
- 68LetPub ·
- h-index
- 99OpenAlex ·
- i10-index
- 828OpenAlex ·
- 2-year mean citedness
- 1.03OpenAlex ·
- Self-citation rate
- 4.9%LetPub ·
- Share of gold OA articles
- 25%LetPub ·
Volume
- Articles per year
- 27LetPub ·
Articles by year OpenAlex count · 1,360 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 23 | 9 | 8 |
| 2025 | 30 | 13 | 27 |
| 2024 | 15 | 6 | 35 |
| 2023 | 32 | 12 | 388 |
| 2022 | 33 | 12 | 293 |
| 2021 | 57 | 22 | 815 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
128 daysMedian, submission to acceptance · P25–P75 97 days – 209 days
- Acceptance to online
- median 17 days (58 articles)
- Submission to online
- median 157 days
- Sample
- 58 articles with submission and acceptance dates (58 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 18.2%Publisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websitePeer review
- Peer review
Impact Factor: 4.1 (Q1 – Dermatology – SCIE) Model summary
Impact Factor: 4.1 (Q1 – Dermatology – SCIE)
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- S. Karger AG
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2004
- ISSN
- 1660-5527
- Electronic ISSN
- 1660-5535
- Latest issue on the website
- Volume 39, Issue 3 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Skin Pharmacology and Physiology
What CAS zone is Skin Pharmacology and Physiology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Skin Pharmacology and Physiology is in Zone 4 of Medicine, and in Zone 3 of the minor category Dermatology / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Skin Pharmacology and Physiology?
The latest impact factor listed by LetPub is 4.05; CiteScore 7, h-index 99.
How long does peer review take at Skin Pharmacology and Physiology?
Based on the dates recorded on 58 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 128 days (interquartile range 97–209 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 18.2%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Skin Pharmacology and Physiology?
According to LetPub and DOAJ records, Skin Pharmacology and Physiology is indexed in SCIE and Scopus.
Is Skin Pharmacology and Physiology open access, and what is the APC?
Skin Pharmacology and Physiology is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .